1. Home
  2. ADCT vs QMCO Comparison

ADCT vs QMCO Comparison

Compare ADCT & QMCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$1.13

Market Cap

136.1M

Sector

Health Care

ML Signal

HOLD

Logo Quantum Corporation

QMCO

Quantum Corporation

HOLD

Current Price

$11.67

Market Cap

129.1M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ADCT
QMCO
Founded
2011
1980
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electronic Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
136.1M
129.1M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
ADCT
QMCO
Price
$1.13
$11.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$7.75
$10.50
AVG Volume (30 Days)
796.4K
861.8K
Earning Date
05-04-2026
02-17-2026
Dividend Yield
N/A
N/A
EPS Growth
30.86
64.34
EPS
N/A
N/A
Revenue
$81,357,000.00
$372,827,000.00
Revenue This Year
N/A
$0.32
Revenue Next Year
$66.49
$8.35
P/E Ratio
N/A
N/A
Revenue Growth
14.85
6.65
52 Week Low
$0.78
$4.19
52 Week High
$4.98
$18.48

Technical Indicators

Market Signals
Indicator
ADCT
QMCO
Relative Strength Index (RSI) 40.67 53.83
Support Level $1.03 $9.57
Resistance Level $1.17 $12.81
Average True Range (ATR) 0.07 1.10
MACD 0.02 0.13
Stochastic Oscillator 41.18 61.21

Price Performance

Historical Comparison
ADCT
QMCO

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. Additionally, the company's development pipeline comprises LOTIS-2, LOTIS-5, LOTIS-7, and ADCT-241, being developed as potential therapies for different cancer diseases. Geographically, the firm generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

About QMCO Quantum Corporation

Quantum Corp is a United States-based company that delivers end-to-end data management solutions designed for unstructured data in the era of artificial intelligence (AI). It provides one of the comprehensive and cost-efficient solutions for the entire data lifecycle. The group provides solutions for video, images, audio, and other large files because this unstructured data represents. Its portfolio of products includes primary storage software and systems, secondary storage software and systems, as well as devices and media. The group operates in three geographic regions: Americas, Europe, the Middle East, and Africa (EMEA), and Asia Pacific (APAC).

Share on Social Networks: